As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...

The research, led by renowned obesity researcher and Phenomix co-founder, Andres Acosta, MD, PhD, and presented by Thomas ...

WHEN Caitlin Cameron started taking fat jabs, she saw dramatic results – losing two stone in just three months. But for the ...

For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes.

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, ...

The Irish public is being urged not to use illegal weight loss drugs after a stark rise in illegal medicines being detained.

The global race for weight loss solutions has firmly arrived in India—bringing with it hope, hype, and a host of unanswered ...

But Hims & Hers' shares fell in after-hours trading as second-quarter projections fell short of analysts' expectations. The ...

Hims & Hers Health first-quarter revenue more than doubled as subscribers rose 38%, while its second-quarter sales outlook ...